CCR5 N-terminus peptides enhance X4 HIV-1 infection by CXCR4 up-regulation

Biochemical and Biophysical Research Communications

Volumn 307, Issue 3, 2003, Pages 640-646

  Dettin, M ^a   Zanchetta, M ^a   Pasquato, A ^a   Borrello, M ^a   Piatier Tonneau, D ^b   Di Bello, C ^a   De Rossi, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNRS   (France)

Author keywords

AIDS; CCR5; CD4; CXCR4; gp120; HIV 1; Peptide; Sulfated tyrosines; Up regulation; Viral entry

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; PEPTIDE; PROTEIN DERIVATIVE; TYROSINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POINT MUTATION; PRIORITY JOURNAL; SULFATION; UPREGULATION; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0043172640     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01237-3     Document Type: Article

References (18)

1. Berger E.A., Murphy P.M., Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:1999;657-700.
2. Trkola A., Dragic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., Moore J.P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature. 384:1996;184-187.
3. Dragic T., Trkola A., Lin S.W., Nagashima K.A., Kajumo F., Zhao L., Olson W.C., Wu L., Mackay C.R., Allaway G.P., Sakamr T.P., Moore J.P., Maddon P.J. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:1998;279-285.
4. Connor R.I., Sheridan K.E., Ceradini D., Choe S., Landau N.R. Change in coreceptor use correlates with desease progression in HIV-1 infected individuals. J. Exp. Med. 185:1997;621-628.
5. Simmons G., Wilkinson D., Reevers J.D., Dittmar M.T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P.W., Weiss R.A., Clapham P.R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and must can use either Lestr or CCR5 as coreceptor for virus entry. J. Virol. 70:1996;8355-8360.
6. Atchison R.E., Gosling J., Monteclaro F.S., Franci C., Digilio L., Charo I.F., Goldsmith M.A. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokine. Science. 274:1996;1924-1926.
7. Picard L., Simmons G., Power C.A., Meyer A., Weiss R.A., Clapham P.R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71:1997;5003-5011.
8. Blanpain C., Doranz B.J., Vakili J., Rucker J., Govaerts C., Baik S.S.W., Lorthioir O., Migeotte I., Libert F., Baleux F., Vassart G., Doms R.W., Parmentier M. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 env protein. J. Biol. Chem. 274:1999;34719-34727.
9. Doranz B.J., Lu Z.H., Rucker J., Zhang T.Y., Sharron M., Cen Y.H., Wang Z.X., Guo H.H., Du J.G., Accavitti M.A., Doms R.W., Peiper S.C. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71:1997;6305-6314.
10. Farzan M., Choc H., Vaca L., Martin K., Sun Y., Desjardins E., Ruffing N., Wu L., Wyatt R., Gerard N., Gerard C., Sodroski J. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1998;1160-1164.
11. Rabut G.E., Konner J.A., Kajumo F., Moore J.P., Dragic T. Alanine substitutions of polar and non polar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;3464-3468.
12. Farzan M., Mirzabckov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., Choc H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV entry. Cell. 96:1999;667-676.
13. Cormier E.G., Persuh M., Thompson D.A.D., Lin S.W., Sakmar T.P., Olson W.C., Dragic T. Specific interaction of CCR5 amino-terminal domain peptides containing sulfo-tyrosines with HIV-1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA. 97:2000;5762-5767.
14. Farzan M., Vasilieva N., Schnitzler C.E., Chung S., Robinson J., Gerard N., Gerard C., Sodroski J. A tyrosine-sulfated peptide based on the N-terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J. Biol. Chem. 275:2000;33516-33521.
15. Olson W.C., Rabut G.e., Nagashima K.A., Tran D.N., Anselma D.J., Monard S.P., Segal J.P., Thompson D.A., Kajumo F., Guo Y., Moore J.P., Maddon P.J., Dragic T. Differential inhibition of human immunodeficiency type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73:1999;4145-4155.
16. Wu L., LaRosa G., Kassam N., Gordon C.J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentieer M., Moore J.P., Mackay C.R. Interaction of the chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1997;1373-1381.
17. Hill C.M., Deng H., Unutmaz D., Kevalramani V.N., Bastiani L., Gorny M.K., Pazner S.Z., Littman D.R. Envelope glycoprotein from human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 97:1997;6296-6304.
18. Labrosse B., Brelot A., Heveker N., Sol N., Schols D., De Clercq E., Alizon M. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100. J. Virol. 8:1998;6381-6388.